Browsing Tag
antiviral pipeline
1 post
CD388 in focus as Merck announces $9.2bn deal for Cidara Therapeutics (NASDAQ: CDTX)
Merck is acquiring Cidara Therapeutics for $9.2B to expand into long-acting antivirals. Find out what makes CD388 a potential flu game-changer.